Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease

Ítems similars

• Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors
  per: Brunetti, Leonardo, et al.
  Publicat: (2020)
• Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-α nuclear receptors
  per: Mazzola, Carmen, et al.
  Publicat: (2009)
• The Discovery and Development of Inhibitors of Fatty Acid Amide Hydrolase (FAAH)
  per: Otrubova, Katerina, et al.
  Publicat: (2011)
• Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and Inflammation
  per: Schlosburg, Joel E., et al.
  Publicat: (2009)
• α-Ketoheterocycle-Based Inhibitors of Fatty Acid Amide Hydrolase (FAAH)
  per: Otrubova, Katerina, et al.
  Publicat: (2011)